Compounds > 2-chloro-n(6)cyclopentyladenosine
Page last updated: 2024-09-03

2-chloro-n(6)cyclopentyladenosine and mre 3008-f20

2-chloro-n(6)cyclopentyladenosine has been researched along with mre 3008-f20 in 2 studies

Compound Research Comparison

Studies
(2-chloro-n(6)cyclopentyladenosine)		Trials
(2-chloro-n(6)cyclopentyladenosine)		Recent Studies (post-2010)
(2-chloro-n(6)cyclopentyladenosine)		Studies
(mre 3008-f20)		Trials
(mre 3008-f20)		Recent Studies (post-2010) (mre 3008-f20)
2520432708

Protein Interaction Comparison

ProteinTaxonomy2-chloro-n(6)cyclopentyladenosine (IC50)mre 3008-f20 (IC50)
Adenosine receptor A3Homo sapiens (human)0.0048

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gao, ZG; Jacobson, KA1
Ahn, S; Cheong, JH; Jacobson, KA; Jeong, LS; Jin, SH; Kim, G; Kim, HJ; Kim, J; Lee, E; Lee, M; Noh, M; Yu, J1

Reviews

1 review(s) available for 2-chloro-n(6)cyclopentyladenosine and mre 3008-f20

ArticleYear
Adenosine receptors as therapeutic targets.
    Nature reviews. Drug discovery, 2006, Volume: 5, Issue:3

    Topics: Animals; Disease; Drug Therapy; Humans; Ligands; Molecular Structure; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Signal Transduction; Structure-Activity Relationship

2006

Other Studies

1 other study(ies) available for 2-chloro-n(6)cyclopentyladenosine and mre 3008-f20

ArticleYear
Polypharmacology of N
    Journal of medicinal chemistry, 2017, 09-14, Volume: 60, Issue:17

    Topics: Adenosine; Adenosine A3 Receptor Agonists; Adenosine A3 Receptor Antagonists; Adiponectin; Animals; Cell Line; Diabetes Mellitus, Experimental; Humans; Hypoglycemic Agents; Insulin Resistance; Ligands; Male; Mice; Mice, Inbred C57BL; Polypharmacology; PPAR delta; PPAR gamma; Receptor, Adenosine A3

2017